You searched for: cancer
1 to 6 of 6 results
Show
results per page
Matched phrases in profile:
Can computers conceive the complexity of cancer to cure it? Using artificial intelligence technology in cancer modelling and drug discovery… Advancing Targeted Therapies for Metastatic Breast and Gynaecologic Cancers using RNA-based Therapeutics with Lipid Nanoparticle (LNP) Delivery System… BACKGROUND Cancer ranks as the second leading cause of death globally and Breast cancer (BC… Cancer Biology and Therapeutics… addressing cancer molecular mechanisms with the goal of developing novel cancer therapeutics and… , further complicated in the context of cancer research by the inherent heterogeneity and complexity of…
I am a Principal Investigator (PI) and a senior research officer (SRO) at Mater research – UQ with excellent clinical and research laboratory skills and expertise in conducting and analyzing laboratory assays and resolving complex research and clinical laboratory problems. I can describe myself as …
Matched phrases in profile:
Head and neck cancers (HNC) are the 7th most common cancer and account for 2,500 new cases in… Applications in lung, skin, and head and neck cancers.… Transformation or progression from adenocarcinoma to small cell lung cancer detected by serially tracking mutations in the blood… From Pixels to Prognosis: Harnessing single-cell spatial analysis to predict and improve immunotherapy response in lung cancer… approaches in the Asia-Pacific region, contributing to world-first studies for lung cancer, head… cancers (HNCs). Whilst the prognostic and predictive value of single CTCs have been well documented…
Dr Arutha Kulasinghe is a Senior Research Fellow and leads the Clinical-oMx Lab at the University of Queensland. Dr Kulasinghe has pioneered spatial transcriptomics using digital spatial profiling approaches in the Asia-Pacific region, contributing to world-first studies for lung cancer, head and ne …
Matched phrases in profile:
Autoantibodies as diagnostic and prognostic cancer biomarker: detection techniques and approaches… A nanoarchitectured platform for early diagnosis and monitoring of ovarian cancer… Dr Mostafa Kamal Masud is a CCQ Next Generation Cancer Research Fellow at the Australian… emerging as an attractive biomarker for early detection of cancer. These serum immunobiomarkers are…
Dr Mostafa Kamal Masud is a CCQ Next Generation Cancer Research Fellow at the Australian Institute for Bioengineering & Nanotechnology (AIBN), the University of Queensland (UQ). In 2020, he received his PhD in Medical Biotechnology Diagnostics and Nanobiotechnology from AIBN, UQ. He received his MS …
Dr Masud pioneered the synthesis of new classes of superparamagnetic nanostructures specific to targeting biomarkers or capturing antibodies. His synthesized nanostructures perform rapid isolation based on simple magnetism and exhibit intrinsic peroxidase activities, substantially replacing the expe …
Matched phrases in profile:
eMethylsorb: rapid quantification of DNA methylation in cancer cells on screen-printed gold electrodes… Combined TMPRSS2:ERG, PCA3 and SChLAP1 RNA in Urine for selective detection of Aggressive Prostate Cancer… biomarkers in prostate cancer liquid biopsies (with a particular interest in fusion genes), and the… Microfabricated devices for the electrochemical detection of single DNA base changes in cancer cell…
Dr Kevin M. Koo is currently a National Health and Medical Research Council (NHMRC) Investigator Fellow at The University of Queensland Centre for Clinical Research (UQCCR). Dr Koo was awarded his PhD (Dean’s Award for Outstanding Thesis) from the Australian Institute for Bioengineering & Nanotech …
To date, Dr Koo's research has contributed Knowledge Impact by:
Matched phrases in profile:
Local doxorubicin delivery via 3Dāprinted porous scaffolds reduces systemic cytotoxicity and breast cancer recurrence in mice… projects on cancer and bone tissue engineering. Dr Shafiee has developed innovative tissue engineered… The concept of using macroscale porous scaffolds as local drug reservoirs to prevent cancer…
Dr Abbas Shafiee is a tissue engineering & regenerative medicine scientist interested in translational cell-based and tissue engineering strategies to treat human diseases.
Dr Shafiee completed his PhD in Professor Kiarash Khosrotehrani’s laboratory on stem cell biology. His research career durin …
My research program has been devoted to understanding human tissue development to develop advanced technologies for tissue regeneration.
Matched phrases in profile:
cancer treatment such as development of multi-drug resistance and limited drug potency, due to inadequate concentration at the cell surface .… Monoclonal antibody-targeted polymeric nanoparticles for cancer therapy - future prospects… ACRF Facility for Targeted Radiometals in Cancer (AFTRiC)… cancer and rheumatoid arthritis. At the next level we now seek cures and therapies for presently…
Professor Stephen Mahler is a Senior Group Leader at the Australian Institute for Bioengineering and Nanotechnology and Director of the Australian Research Council Training Centre for Biopharmaceutical Innovation (CBI), University of Queensland. Professor Mahler is a biotechnologist with a focus on …
Professor Mahler has a strong engagement with industry both nationally and internationally, that through collaborative research has led to some significant translational outcomes including clinical trial of biopharmaceutical drug candidates through to approval. The Australian Research Council Traini …
1 to 6 of 6 results